MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216

PURPOSE: Aim of this study was to demonstrate that MDCO-216 (human recombinant Apolipoprotein A-I Milano) does not induce adverse immunostimulation, in contrast to its predecessor, ETC-216, which was thought to contain host cell proteins (HCPs) that elicited an inflammatory reaction. METHODS: Data w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cardiovasc Drugs Ther
Asıl Yazarlar: Reijers, Joannes A. A., Kallend, D. G., Malone, K. E., Jukema, J. W., Wijngaard, P. L. J., Burggraaf, J., Moerland, M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5591804/
https://ncbi.nlm.nih.gov/pubmed/28844118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-017-6746-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller